Sofia Kaufman

Chief People and Customer Officer, Growth Enabler, Change Agent

πŸ“ United StatesπŸ”„ Updated September 2026πŸ’Ό 1 investmentsπŸ“… 1 years investingπŸ—“ Last invested Jan 2025
Operator-angel🌍 United States
1
Total investments
1
Early stage
0
Mid stage
0
Late stage
1y
Years active

Portfolio

1 investments Β· sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor and Advisor
Jan 2025
Graphio stops revenue loss before it happens by detecting broken handoffs between teams. We analyze API-enabled metadata from your existing systems to automatically identify when Sales, CS, Legal, Finance, Product, and Operations are misaligned before deals stall, renewals fail, or contracts slip. Technically, It’s a Context-Change Graph AI that learns your companys blueprint for success. It tracks live performance against that map to predict, alert, and repair dangerous deviations the moment they happen Zero integrations. Zero workflow disruption. Privacy by design: we dont analyze your content - only metadata. Launch in under 48 hours. SOC 2 Type 2, HIPAA compliant.
Experience Β· 2 entries
All (2)
Investments (1)
Founder (1)
2025
Investor and Advisor
Jan 2025
Graphio stops revenue loss before it happens by detecting broken handoffs between teams. We analyze API-enabled metadata from your existing systems to automatically identify when Sales, CS, Legal, Finance, Product, and Operations are misaligned before deals stall, renewals fail, or contracts slip. Technically, It’s a Context-Change Graph AI that learns your companys blueprint for success. It tracks live performance against that map to predict, alert, and repair dangerous deviations the moment they happen Zero integrations. Zero workflow disruption. Privacy by design: we dont analyze your content - only metadata. Launch in under 48 hours. SOC 2 Type 2, HIPAA compliant.
2019
Founder and Principal
2019
SK Consulting provides full scale Human Resources consulting to companies undergoing transformation. Clients include leading global technology firms, Private Equity, and biopharma startups.